Inhibition of Tumorigenicity and Metastasis of Human Melanoma Cells by Anti-Cathepsin L Single Chain Variable Fragment

Cancer Research

Volumn 64, Issue 1, 2004, Pages 146-151

  Rousselet, Nathalie ^a   Mills, Lisa ^b   Jean, Didier ^a   Tellez, Carmen ^b   Bar Eli, Menashe ^b   Frade, Raymond ^a,c  

^a Parc Scientifique de Luminy   (France)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; COMPLEMENT COMPONENT C3; CYSTEINE PROTEINASE; MATRIGEL; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOGENICITY; CELL CLONE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SECRETION; TUMOR GROWTH;

ANIMALS; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LUNG NEOPLASMS; MELANOMA; MICE; MICE, NUDE; NEOPLASM METASTASIS; RECOMBINANT PROTEINS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 1642535587     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1717     Document Type: Article

References (30)

1. Bar-Eli, M. Role of AP-2 in tumor growth and metastasis of human melanoma. Cancer Metastasis Rev., 18: 377-385, 1999.
2. Bar-Eli, M. Gene regulation in melanoma progression by the AP-2 transcription factor. Pigment Cell Res., 14: 78-85, 2001.
3. Jean, D., Hermann, J., Rodrigues-Lima, F., Barel, M., Balbo, M., and Frade, R. Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L. Biochem. J., 312: 961-969, 1995.
4. Frade, R. Structure and signaling functions of C3 receptors on human B lymphocytes. In: G. B. Klaus (ed.), Seminar in Immunology, Transmembrane Signalling in Lymphocytes, pp. 159-164. Philadelphia: W. B. Saunders Scientific Publishing Co., 1990.
5. Jean, D., Rodrigues-Lima, F., Cassinat, B., Hermann, J., Cabane, J., and Frade, R. Co-expression and secretion of C3, the third component of complement and a C3-cleaving cysteine proteinase in a highly metastatic human melanoma cell line. Immunol. Lett., 58: 107-112, 1997.
6. Ishidoh, K., Towatari, T., Imajoh, S., Kawasaki, H., Kominami, E., Katunuma, N., and Suzuki, K. Molecular cloning and sequencing of cDNA for rat cathepsin L. FEBS Lett., 223: 69-73, 1987.
7. Troen, B. R., Gal, S., and Gottesmann, M. M. Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. A secreted lysosomal protease regulated by transformation. J. Biol. Chem., 263: 254-261, 1987.
8. Turk, B., Turk, D., and Turk, V. Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta. 1477: 98-111, 2000.
9. Chauhan, S. S., Popescu, N. C., Ray, D., Fleischmann, R., Gottesman, M. M., and Troen, B. R. Cloning, genomic organization, and chromosomal localization of human cathepsin L. J. Biol. Chem., 268: 1039-1045, 1993.
10. Ishidoh, K., and Kominami, E. Gene regulation and extracellular functions of procathepsin L. Biol. Chem., 379: 131-135, 1998.
11. Gal, S., and Gottesmann, M. M. The major excreted protein (MEP) of transformed mouse cells and cathepsin L have similar protease specificity. Biochem. Biophys. Res. Commun., 139: 156-162, 1986.
12. Kirschke, H., and Barrett, A. J. Lysosomal cysteine proteases. In: H. Glaumann and F. J. Ballard (eds.), Lysosomes: Their Role in Protein Breakdown, pp. 193-238. London: Academic Press, 1987.
13. Jean, D., Bar-Eli, M., Huang, S., Xie, K., Rodrigues-Lima, F., Hermann, J., and Frade, R. A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma. Cancer Res., 56: 254-258, 1996.
14. Frade, R., Rodrigues-Lima, F., Huang, S., Xie, K., Guillaume, N., and Bar-Eli, M. Procathepsin L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res., 58: 2733-2736, 1998.
15. Gottesmann, M. M., and Sobel, M. E. Tumor promoters and Kirsten sarcoma virus increase synthesis of a secreted glycoprotein by regulating levels of translatable mRNA. Cell, 19: 449-455, 1980.
16. Chauhan, S. S., Goldstein, L. J., and Gottesman, M. M. Expression of cathepsin L in human tumors. Cancer Res., 51: 1478-1481, 1991.
17. Kirschke, H., Eerola, R., Hopsu-Havu, V. K., Bromme, D. and Vuorio, E. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Eur. J. Cancer, 36: 787-795, 2000.
18. Jean, D., Guillaume, N., and Frade, R. Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity. Biochem. J., 361: 173-184, 2002.
19. Frade, R. Structure and functions of proteases which cleave human C3 and are expressed on normal or tumor human cells: some are involved in tumorigenic and metastatic properties of human melanoma cells. Immunopharmacology, 42: 39-45, 1999.
20. Felbor, U., Dreier, L., Bryant, R. A., Ploegh, H. L., Olsen, B. R., and Mothes, W. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J., 19: 1187-1194, 2000.
21. Guillaume-Rousselet, N., Jean, D., and Frade, R. Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells. Biochem. J., 367: 219-227, 2002.
22. Kozlowski, J. M., Hart, I. R., Fidler, I. J., and Hanna, N. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Cancer Inst. (Bethesda), 72: 913-917, 1984.
23. Li, L., Price, J. E., Fan, D., Zhang, R. D., Bucana, C. D., and Fidler, I. J. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J. Natl. Cancer Inst. (Bethesda), 81: 1406-1412, 1989.
24. Barel, M., Fiandino, A., Lyamani, F., and Frade, R. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies. Proc. Natl. Acad. Sci. USA, 86: 10054-10058, 1989.
25. Mills, L., Tellez, C., Huang, S., Baker, C., McCarty, M., Green, L., Gudas, J. M., Feng, X., and Bar-Eli, M. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res., 62: 5106-5114, 2002.
26. Frade, R., Balbo, M., and Barel, M. RBI8A regulates p53-dependent apoptosis. Oncogene, 21: 861-866, 2002.
27. Stumptner-Cuvelette, P., and Benaroch, P. Multiple roles of the invariant chain in MHC class II function. Biochim. Biophys. Acta, 1542: 1-13, 2002.
28. Nistico, P., Tecce, R., Giacomini, P., Cavallari, A., D'Agnano, L., Fisher, P. B., and Natali, P. G. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells. Cancer Res., 50: 7422-7429, 1990.
29. Fiebiger, E., Maehr, R., Villadangos, J., Weber, E., Erickson, A., Bikoff, E. Ploegh, H. L., and Lennon-Dumenil., A. M. Invariant chain controls the activity of extracellular cathepsin L. J. Exp. Med., 196: 1263-1269, 2002.
30. Lennon-Dumenil, A. M., Roberts, R. A., Valentijn, K., Driessen, C., Overkleeft, H. S., Erickson, A., Peteres, P. J., Bikoff, E., Ploegh, H. L., and Wolf-Bryant, P. The p41 isoform of invariant chain is a chaperone for cathepsin L. EMBO J., 20: 4055-4064, 2001.